Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 26, 2025 19:15 ET | Source: Robbins LLP

UNCY Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Unicycive Therapeutics, Inc. Class Action

Robbins LLP is Investigating Allegations that Unicycive Therapeutics, Inc. (UNCY) Misled Investors Regarding the Readiness of its Drug Prospect
August 26, 2025 19:13 ET | Source: Robbins LLP

CHTR Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Charter Communications, Inc. Class Action

Robbins LLP is Investigating Allegations that Charter Communications, Inc. (CHTR) Misled Investors Regarding its Business Prospects
August 25, 2025 19:37 ET | Source: Robbins LLP

C3.ai, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against C3.ai, Inc.

Robbins LLP is Investigating Allegations that C3.ai, Inc. (AI) Misled Investors Regarding the Impact of its CEO's Health on its Business Prospects
August 25, 2025 19:31 ET | Source: Robbins LLP

Nutex Health Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Nutex Health Inc.

Robbins LLP is Investigating Allegations that Nutex Health Inc. (NUTX) Failed to Disclose Fraud Committed by its Third-Party Arbitration Vendor
August 22, 2025 19:39 ET | Source: Robbins LLP

PUBM Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PubMatic, Inc.

Robbins LLP is Investigating Allegations that PubMatic, Inc. (PUBM) Misled Investors Regarding its Business Prospects
August 22, 2025 19:38 ET | Source: Robbins LLP

SNAP Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Snap Inc.

Robbins LLP is Investigating Allegations that Snap Inc. (SNAP) Misled Investors Regarding its Business Prospects
August 22, 2025 19:14 ET | Source: Robbins LLP

SLQT Stockholders with Large Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the SelectQuote, Inc. Class Action

Robbins LLP is Investigating Allegations that SelectQuote, Inc. (SLQT) Violated the False Claims Act
August 18, 2025 17:56 ET | Source: Robbins LLP

Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT

Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
August 14, 2025 19:28 ET | Source: Robbins LLP

Robbins LLP Urges LINE Investors with Large Losses to Contact the Firm for Information About Leading the LINE Securities Fraud Class Action

Robbins LLP is Investigating Allegations that Lineage, Inc. (LINE) Misled Investors in Connection with its IPO
August 14, 2025 19:25 ET | Source: Robbins LLP

Robbins LLP Urges NVO Stockholders with Large Losses to Contact the Firm for Information about Leading the Class Action Against Novo Nordisk A/S

Robbins LLP is Investigating Allegations that Novo Nordisk A/S (NVO) Misled the Market About its 2025 Revenue and Profit Growth Potential